Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: Sequential or simultaneous start?

Diabetes Obes Metab · 2017

Last updated 2026-05-28

Journal	Diabetes Obes Metab, 2017
Citations	14
Relative citation ratio	0.46
NIH percentile	27
Molecules	—
Conditions studied	Type 2 Diabetes, Cardiovascular Risk Reduction, Obesity, Chronic Kidney Disease

Full record and abstract on PubMed 28176440 ↗